Home
Name
CHOR
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CHOR
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
123127
Primary Site
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded
Name
Alternate Names
Ancef
Apo-Cefaclor
Apo-Cephalex
Ceclor
Ceclor CD
Cedax
Cefaclor
Cefadroxil
Cefadyl
Cefamandole
Cefazolin
Cefdinir
Cefditoren
Cefepime
Cefixime
Cefizox
Cefobid
Cefonicid
Cefoperazone
Cefotan
Cefotaxime
Cefotetan
Cefoxitin
Cefpodoxime
Cefprozil
Ceftazidime
Ceftibuten
Ceftin
Ceftizoxime
Ceftriaxone
Cefuroxime
Cefzil
Cephalexin
Cephalothin
Cephapirin
Cephradine
Ceporacin
Ceptaz
Claforan
Duricef
Fortaz
Keflex
Keflin
Keftab
Kefurox
Kefzol
Mandol
Maxipime
Mefoxin
Monocid
Novo-Lexin
Nu-Cephalex
Omnicef
PMS-Cephalexin
Rocephin
Suprax
Tazicef
Tazidime
Vantin
Velosef
Zinacef
Abbreviations
None
Category
Ancillary Agent
Subcategory
Antibacterial
NSC Number
None
Primary Site
None
Histology
None
Remarks
None
Coding
This drug should NOT be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded
